Zobrazeno 1 - 10
of 30
pro vyhledávání: '"MESH: Calcineurin"'
Autor:
Christophe Duvoux, Daniel Eyraud, Rodolphe Sobesky, Guillaume Lasailly, Audrey Coilly, Sylvie Tresson, Olivier Boillot, Didier Samuel, Teresa Antonini, Valérie Cailliez, Yvon Calmus, Georges Philippe Pageaux, Martine Neau-Cransac, Faouzi Saliba, Ephrem Salamé, Eléonora Demartin, Sylvie Radenne, Jean Guguenheim, Jérôme Dumortier, Filomena Conti, Olivier Guillaud, Sébastien Dharancy
Publikováno v:
Liver Transplantation
Liver Transplantation, Wiley, 2020, 26 (11), pp.1465-1476. ⟨10.1002/lt.25879⟩
Liver Transplantation, Wiley, 2020, 26 (11), pp.1465-1476. ⟨10.1002/lt.25879⟩
International audience; Longterm use of a calcineurin inhibitor (CNI)-based regimen is one of the major reasons for chronic renal failure in liver transplantation recipients (LTRs). The Everolimus Liver registry (EVEROLIVER) evaluated renal function
Autor:
Stéphanie Faure, Matthias Niemann, Magdalena Meszaros, José Ursic-Bedoya, Céline Thevenin, Georges-Philippe Pageaux, Lucy Meunier, Benjamin Rivière, Valérie Costes-Martineau
Publikováno v:
Transplant Immunology
Transplant Immunology, Elsevier, 2020, 59, pp.101272. ⟨10.1016/j.trim.2020.101272⟩
Transplant Immunology, Elsevier, 2020, 59, pp.101272. ⟨10.1016/j.trim.2020.101272⟩
International audience; The PIRCHE (Predicted Indirectly ReCognizable HLA Epitopes) score is an HLA epitope matching algorithm. PIRCHE algorithm estimates the level of presence of T-cell epitopes in mismatched HLA. The PIRCHE-II numbers associate wit
Autor:
BOUCHEREAU, juliette
Publikováno v:
Médecine humaine et pathologie. 2016
Idiopathic nephrotic syndrome (NS) is the major acquired glomerular disease of children. His main treatment is corticosteroids, but 10-20% of patients are steroid-resistants. For these patients, prognosis depends on decreasing of proteinuria, with a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2592::c352cb3538f5baf6bf426d210e0dd984
https://dumas.ccsd.cnrs.fr/dumas-01513852/file/ThExe_BOUCHEREAU_Juliette_DUMAS.pdf
https://dumas.ccsd.cnrs.fr/dumas-01513852/file/ThExe_BOUCHEREAU_Juliette_DUMAS.pdf
Autor:
Pierre Merville, Marie-Christine Moal, Jacques Dantal, Christophe Legendre, Nassim Kamar, Stéphane Quéré, Jean Philippe Rerolle, Bruno Moulin, Fabienne Di Giambattista, Laetitia Albano, Rachel Tetaz, Olivier Toupance, Arara Terpereau, Eric Alamartine
Publikováno v:
Annals of Transplantation
Annals of Transplantation, Springer Verlag (Germany), 2014, 17 (1), pp.58-67
Annals of Transplantation, 2014, 17 (1), pp.58-67
Annals of Transplantation, Springer Verlag (Germany), 2014, 17 (1), pp.58-67
Annals of Transplantation, 2014, 17 (1), pp.58-67
International audience; BACKGROUND: Data in kidney transplant recipients regarding elimination of calcineurin inhibitor (CNI) therapy from a de novo regimen based on low CNI exposure and an mTOR inhibitor are sparse, and restricted to CNI elimination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc0357f0eb3b9d101e32831b851411ba
http://www.hal.inserm.fr/inserm-00925721
http://www.hal.inserm.fr/inserm-00925721
Publikováno v:
Journal of Cellular and Molecular Medicine
Journal of Cellular and Molecular Medicine, Wiley Open Access, 2012, 16 (2), pp.218-27. ⟨10.1111/j.1582-4934.2011.01398.x⟩
Journal of Cellular and Molecular Medicine, Wiley Open Access, 2012, 16 (2), pp.218-27. ⟨10.1111/j.1582-4934.2011.01398.x⟩
International audience; Calcineurin is a serine/threonine phosphatase originally involved in the immune response but is also known for its role as a central mediator in various non-immunological intracellular signals. The nuclear factor of activated
Autor:
Jean-Marc Chalopin, Yves Vanrenterghem, Lionel Rostaing, Bernard Bourbigot, François Berthoux, Daniel Abramovicz, Bernard Charpentier, Nicole Lefrançois, Michel Delahousse, Elisabeth Cassuto, Gérard Rifle, Denis Glotz, Philippe Lang
Publikováno v:
Transplantation
Transplantation, Lippincott, Williams & Wilkins, 2010, 89 (12), pp.1511-7. ⟨10.1097/TP.0b013e3181db09e4⟩
Transplantation, 2010, 89 (12), pp.1511-7. ⟨10.1097/TP.0b013e3181db09e4⟩
Transplantation, Lippincott, Williams & Wilkins, 2010, 89 (12), pp.1511-7. ⟨10.1097/TP.0b013e3181db09e4⟩
Transplantation, 2010, 89 (12), pp.1511-7. ⟨10.1097/TP.0b013e3181db09e4⟩
International audience; BACKGROUND: To define the role of mammalian target of rapamycin inhibitors in kidney transplantation, we compared efficacy and safety of two immunosuppressive regimens-a calcineurin inhibitor-free regimen with depletive induct
Autor:
Jochen Schmitt, Hywel C Williams, Sinead Langan, Kim S Thomas, Caroline O'Leary, Beth Stuart, Carle Paul
Publikováno v:
PLoS ONE
PLoS ONE, Public Library of Science, 2015, 10 (4), pp.e0124770. ⟨10.1371/journal.pone.0124770⟩
PLoS ONE, Vol 10, Iss 4, p e0124770 (2015)
PLoS ONE, Public Library of Science, 2015, 10 (4), pp.e0124770. ⟨10.1371/journal.pone.0124770⟩
PLoS ONE, Vol 10, Iss 4, p e0124770 (2015)
Background Atopic eczema (AE) is a chronic disease with flares and remissions. Long-term control of AE flares has been identified as a core outcome domain for AE trials. However, it is unclear how flares should be defined and measured. Objective To v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7e6554c05f75cd9b902b28025a19e3d
https://researchonline.lshtm.ac.uk/id/eprint/2300380/1/pone.0124770.pdf
https://researchonline.lshtm.ac.uk/id/eprint/2300380/1/pone.0124770.pdf
Autor:
Rachel Chapot, Renée Ventura-Clapier, André Peinnequin, Bernard Serrurier, Hélène Richard, Valérie Novel-Chaté, Xavier Bigard, Nathalie Koulmann, Nadine Simler
Publikováno v:
American Journal of Respiratory and Critical Care Medicine
American Journal of Respiratory and Critical Care Medicine, American Thoracic Society, 2006, 174 (6), pp.699-705. ⟨10.1164/rccm.200512-1976OC⟩
American Journal of Respiratory and Critical Care Medicine, American Thoracic Society, 2006, 174 (6), pp.699-705. ⟨10.1164/rccm.200512-1976OC⟩
International audience; RATIONALE: Hypoxia-induced pulmonary hypertension involves hypoxia-inducible factor-1alpha (HIF-1alpha) activation as well as elevated resting calcium levels. Cyclosporin A (CsA) inhibits calcium-induced calcineurin activation
Autor:
Yvon Calmus, Emmanuel Boleslawski, Y. de Launoit, Véronique Pancré, Lynda Aoudjehane, Nadira Delhem, L. Ouaguia, Olivier Moralès, Céline Miroux, Filomena Conti
Publikováno v:
Transplantation Proceedings
Transplantation Proceedings, 2012, 44 (9), pp.2834-2839. ⟨10.1016/j.transproceed.2012.09.091⟩
Transplantation Proceedings, Elsevier, 2012, 44 (9), pp.2834-2839. ⟨10.1016/j.transproceed.2012.09.091⟩
Transplantation Proceedings, 2012, 44 (9), pp.2834-2839. ⟨10.1016/j.transproceed.2012.09.091⟩
Transplantation Proceedings, Elsevier, 2012, 44 (9), pp.2834-2839. ⟨10.1016/j.transproceed.2012.09.091⟩
International audience; BACKGROUND: Inevitable hepatitis C virus recurrence after liver transplantation, a major barrier to survival of the transplanted liver may be promoted by immunosuppression and by CD4(+)CD25(+) regulatory T cells (Treg). Treg c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3200b1858c131c8084716418afb0113
https://hal.archives-ouvertes.fr/hal-03059987
https://hal.archives-ouvertes.fr/hal-03059987
Autor:
Olivier Moralès, Nadira Delhem, Yvan de Launoit, Véronique Pancré, Céline Miroux, Filomena Conti, Khaldoun Ghazal, Samia Ben Othman
Publikováno v:
Transplantation
Transplantation, 2012, 94 (2), pp.123-31. ⟨10.1097/TP.0b013e3182590d8f⟩
Transplantation, Lippincott, Williams & Wilkins, 2012, 94 (2), pp.123-31. 〈10.1097/TP.0b013e3182590d8f〉
Transplantation, Lippincott, Williams & Wilkins, 2012, 94 (2), pp.123-31. ⟨10.1097/TP.0b013e3182590d8f⟩
Transplantation, Lippincott, Williams & Wilkins, 2012, 94 (2), pp.123-131. ⟨10.1097/TP.0b013e3182590d8f⟩
Transplantation, 2012, 94 (2), pp.123-31. ⟨10.1097/TP.0b013e3182590d8f⟩
Transplantation, Lippincott, Williams & Wilkins, 2012, 94 (2), pp.123-31. 〈10.1097/TP.0b013e3182590d8f〉
Transplantation, Lippincott, Williams & Wilkins, 2012, 94 (2), pp.123-31. ⟨10.1097/TP.0b013e3182590d8f⟩
Transplantation, Lippincott, Williams & Wilkins, 2012, 94 (2), pp.123-131. ⟨10.1097/TP.0b013e3182590d8f⟩
International audience; BACKGROUND: Liver transplantation is the treatment of end-stage liver diseases, including hepatitis C. Immunosuppression prevents graft rejection but seems to accelerate the recurrence of hepatitis C. Regulatory T cells (Tregs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1369a0a3992dac7abd57361a290b4e4c
https://hal.science/hal-00785885
https://hal.science/hal-00785885